Literature DB >> 16464448

Effects of mu-, delta- and kappa-opioid receptor agonists on methamphetamine-induced self-injurious behavior in mice.

Tomohisa Mori1, Shinobu Ito, Taizo Kita, Minoru Narita, Tsutomu Suzuki, Toshiko Sawaguchi.   

Abstract

Opioid receptor agonists can differentially modify the behavioral effects of direct/indirect dopamine receptor agonists, such as methamphetamine, cocaine and apomorphine. However, the effects of opioid receptor agonists on high-dose methamphetamine-induced behavior have not yet been clarified. Therefore, the present study was undertaken to investigate the effects of mu (morphine)-, delta (SNC80)- and kappa (U50,488H)-opioid receptor agonists on methamphetamine-induced self-injurious behavior and locomotor activity in mice. Methamphetamine (20 mg/kg) induced severe self-injurious behavior. In a combination test, some opioid receptor agonists significantly attenuated methamphetamine-induced self-injurious behavior, with potencies in the order morphine>buprenorphine (mu-opioid and kappa-opioid receptor agonist/antagonist) >U50,488H, as maximum effects. These results suggest that the stimulation of mu- and kappa-opioid receptors plays an inhibitory role in high-dose methamphetamine-induced stereotypic self-injurious behavior in mice, without affecting locomotor activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16464448     DOI: 10.1016/j.ejphar.2005.12.035

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

2.  Clinical efficacy of buprenorphine to minimize distress in MRL/lpr mice.

Authors:  Julie Swenson; Selen Olgun; Ali Radjavi; Taranjit Kaur; Christopher M Reilly
Journal:  Eur J Pharmacol       Date:  2007-04-06       Impact factor: 4.432

3.  The selective delta opioid agonist SNC80 enhances amphetamine-mediated efflux of dopamine from rat striatum.

Authors:  Kelly E Bosse; Emily M Jutkiewicz; Margaret E Gnegy; John R Traynor
Journal:  Neuropharmacology       Date:  2008-06-18       Impact factor: 5.250

4.  Synergistic activity between the delta-opioid agonist SNC80 and amphetamine occurs via a glutamatergic NMDA-receptor dependent mechanism.

Authors:  Kelly E Bosse; Emily M Jutkiewicz; Kristin N Schultz-Kuszak; Omar S Mabrouk; Robert T Kennedy; Margaret E Gnegy; John R Traynor
Journal:  Neuropharmacology       Date:  2013-09-10       Impact factor: 5.250

5.  Buprenorphine modulates methamphetamine-induced dopamine dynamics in the rat caudate nucleus.

Authors:  Frederico C Pereira; Bobby Gough; Tice R Macedo; Carlos F Ribeiro; Syed F Ali; Zbigniew K Binienda
Journal:  Neurotox Res       Date:  2009-12-22       Impact factor: 3.911

Review 6.  Brain Histamine N-Methyltransferase As a Possible Target of Treatment for Methamphetamine Overdose.

Authors:  Junichi Kitanaka; Nobue Kitanaka; F Scott Hall; George R Uhl; Motohiko Takemura
Journal:  Drug Target Insights       Date:  2016-03-02

7.  Adrenergic Agonists Bind to Adrenergic-Receptor-Like Regions of the Mu Opioid Receptor, Enhancing Morphine and Methionine-Enkephalin Binding: A New Approach to "Biased Opioids"?

Authors:  Robert Root-Bernstein; Miah Turke; Udaya K Tiruttani Subhramanyam; Beth Churchill; Joerg Labahn
Journal:  Int J Mol Sci       Date:  2018-01-17       Impact factor: 5.923

8.  Comparing the Antinociceptive Effects of Methamphetamine, Buprenorphine, or Both After Chronic Treatment and Withdrawal in Male Rats.

Authors:  Farshid Etaee; Arezoo Rezvani-Kamran; Mohammad Taheri; Ghazaleh Omidi; Parisa Hasanein; Alireza Komaki
Journal:  Basic Clin Neurosci       Date:  2019-07-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.